Literature DB >> 9420227

Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain.

E Herrera1, M M Lorenzo, R Blasco, S N Isaacs.   

Abstract

Vaccinia virus has two forms of infectious virions: the intracellular mature virus and the extracellular enveloped virus (EEV). EEV is critical for cell-to-cell and long-range spread of the virus. The B5R open reading frame (ORF) encodes a membrane protein that is essential for EEV formation. Deletion of the B5R ORF results in a dramatic reduction of EEV, and as a consequence, the virus produces small plaques in vitro and is highly attenuated in vivo. The extracellular portion of B5R is composed mainly of four domains that are similar to the short consensus repeats (SCRs) present in complement regulatory proteins. To determine the contribution of these putative SCR domains to EEV formation, we constructed recombinant vaccinia viruses that replaced the wild-type B5R gene with a mutated gene encoding a B5R protein lacking the SCRs. The resulting recombinant viruses produced large plaques, indicating efficient cell-to-cell spread in vitro, and gradient centrifugation of supernatants from infected cells confirmed that EEV was formed. In contrast, phalloidin staining of infected cells showed that the virus lacking the SCR domains was deficient in the induction of thick actin bundles. Thus, the highly conserved SCR domains present in the extracellular portion of the B5R protein are dispensable for EEV formation. This indicates that the B5R protein is a key viral protein with multiple functions in the process of virus envelopment and release. In addition, given the similarity of the extracellular domain to complement control proteins, the B5R protein may be involved in viral evasion from host immune responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9420227      PMCID: PMC109376     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Inhibition of the complement cascade by the major secretory protein of vaccinia virus.

Authors:  G J Kotwal; S N Isaacs; R McKenzie; M M Frank; B Moss
Journal:  Science       Date:  1990-11-09       Impact factor: 47.728

Review 2.  Complement receptors.

Authors:  M Krych; J P Atkinson; V M Holers
Journal:  Curr Opin Immunol       Date:  1992-02       Impact factor: 7.486

3.  Role of cell-associated enveloped vaccinia virus in cell-to-cell spread.

Authors:  R Blasco; B Moss
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

4.  Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.

Authors:  R Blasco; B Moss
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope.

Authors:  M Engelstad; S T Howard; G L Smith
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

6.  Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene.

Authors:  R Blasco; J R Sisler; B Moss
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

7.  Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress.

Authors:  S A Duncan; G L Smith
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

8.  Regulation of complement activity by vaccinia virus complement-control protein.

Authors:  R McKenzie; G J Kotwal; B Moss; C H Hammer; M M Frank
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226

9.  Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope.

Authors:  S N Isaacs; E J Wolffe; L G Payne; B Moss
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks.

Authors:  B Sodeik; R W Doms; M Ericsson; G Hiller; C E Machamer; W van 't Hof; G van Meer; B Moss; G Griffiths
Journal:  J Cell Biol       Date:  1993-05       Impact factor: 10.539

View more
  41 in total

1.  Golgi network targeting and plasma membrane internalization signals in vaccinia virus B5R envelope protein.

Authors:  B M Ward; B Moss
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence.

Authors:  W H Zhang; D Wilcock; G L Smith
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera.

Authors:  B M Ward; B Moss
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Increased interaction between vaccinia virus proteins A33 and B5 is detrimental to infectious extracellular enveloped virion production.

Authors:  Winnie M Chan; Brian M Ward
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

5.  The A33-dependent incorporation of B5 into extracellular enveloped vaccinia virions is mediated through an interaction between their lumenal domains.

Authors:  Winnie M Chan; Brian M Ward
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

6.  The vaccinia virus B5 protein requires A34 for efficient intracellular trafficking from the endoplasmic reticulum to the site of wrapping and incorporation into progeny virions.

Authors:  Amalia K Earley; Winnie M Chan; Brian M Ward
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

Review 7.  Poxvirus proteomics and virus-host protein interactions.

Authors:  Kim Van Vliet; Mohamed R Mohamed; Leiliang Zhang; Nancy Yaneth Villa; Steven J Werden; Jia Liu; Grant McFadden
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

Review 8.  Vaccinia virus vaccines: past, present and future.

Authors:  Bertram L Jacobs; Jeffrey O Langland; Karen V Kibler; Karen L Denzler; Stacy D White; Susan A Holechek; Shukmei Wong; Trung Huynh; Carole R Baskin
Journal:  Antiviral Res       Date:  2009-06-26       Impact factor: 5.970

9.  Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8.

Authors:  Minoru Kidokoro; Masato Tashiro; Hisatoshi Shida
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

10.  Suppression of NYVAC Infection in HeLa Cells Requires RNase L but Is Independent of Protein Kinase R Activity.

Authors:  Mercedes Fernández-Escobar; José Luis Nájera; Sara Baldanta; Dolores Rodriguez; Michael Way; Mariano Esteban; Susana Guerra
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.